(1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PYGL mRNA CTD PMID:36331819 1,1-dichloroethene decreases expression EXP 6480464 vinylidene chloride results in decreased expression of PYGL mRNA CTD PMID:26682919 1,2-dichloroethane decreases expression EXP 6480464 ethylene dichloride results in decreased expression of PYGL mRNA, ethylene dichloride results in decreased expression of PYGL protein CTD PMID:28189721 , PMID:28960355 1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of PYGL mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene affects binding ISO RGD:731803 6480464 Dinitrochlorobenzene binds to PYGL protein CTD PMID:32991956 1-naphthyl isothiocyanate decreases expression ISO RGD:620687 6480464 1-Naphthylisothiocyanate results in decreased expression of PYGL mRNA CTD PMID:17522070 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PYGL mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:620687 6480464 Ethinyl Estradiol results in increased expression of PYGL mRNA CTD PMID:17557909 17beta-estradiol multiple interactions ISO RGD:731803 6480464 [Estradiol co-treated with Norethindrone Acetate] results in increased expression of PYGL mRNA CTD PMID:22217510 17beta-estradiol multiple interactions ISO RGD:620687 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of PYGL mRNA CTD PMID:26496021 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of PYGL mRNA CTD PMID:19484750 1H-pyrazole decreases expression EXP 6480464 pyrazole results in decreased expression of PYGL mRNA CTD PMID:17945193 2,3',4,4',5-Pentachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PYGL mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PYGL mRNA CTD PMID:19770486 , PMID:27562557 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:731803 6480464 Tetrachlorodibenzodioxin results in increased expression of PYGL mRNA CTD PMID:22903824 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:620687 6480464 Tetrachlorodibenzodioxin results in decreased expression of PYGL mRNA CTD PMID:20959002 , PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PYGL mRNA CTD PMID:21570461 2,4-dinitrotoluene affects expression ISO RGD:620687 6480464 2, 4-dinitrotoluene affects the expression of PYGL mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression ISO RGD:620687 6480464 2, 6-dinitrotoluene affects the expression of PYGL mRNA CTD PMID:21346803 2-hydroxypropanoic acid decreases expression ISO RGD:731803 6480464 Lactic Acid results in decreased expression of PYGL mRNA CTD PMID:30851411 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:620687 6480464 3 more ... CTD PMID:27509375 more ... 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:620687 6480464 AHR protein affects the reaction [3 more ... CTD PMID:34848246 3-chloropropane-1,2-diol increases expression ISO RGD:620687 6480464 alpha-Chlorohydrin results in increased expression of PYGL protein CTD PMID:26597043 3H-1,2-dithiole-3-thione decreases expression ISO RGD:620687 6480464 1, 2-dithiol-3-thione results in decreased expression of PYGL mRNA CTD PMID:19162173 4'-hydroxyacetophenone affects binding ISO RGD:620687 6480464 4-hydroxyacetophenone binds to PYGL protein CTD PMID:15236443 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of PYGL mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression EXP 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PYGL mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol increases expression ISO RGD:731803 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PYGL protein CTD PMID:34186270 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression ISO RGD:620687 6480464 Omeprazole affects the expression of PYGL mRNA CTD PMID:19483382 6-propyl-2-thiouracil affects expression ISO RGD:620687 6480464 Propylthiouracil affects the expression of PYGL mRNA CTD PMID:19483382 8-Br-cAMP decreases expression ISO RGD:731803 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PYGL mRNA CTD PMID:22079614 acetylsalicylic acid affects binding ISO RGD:620687 6480464 Aspirin binds to PYGL protein CTD PMID:15236443 acrylamide increases expression ISO RGD:620687 6480464 Acrylamide results in increased expression of PYGL mRNA CTD PMID:31644924 acrylamides affects binding ISO RGD:731803 6480464 Acrylamides analog binds to PYGL protein CTD PMID:18723356 acrylamides decreases activity ISO RGD:731803 6480464 Acrylamides analog results in decreased activity of PYGL protein CTD PMID:18723356 aldehydo-D-glucose multiple interactions ISO RGD:620687 6480464 Glucose inhibits the reaction [[Phenylephrine co-treated with Calcium] results in increased activity of PYGL protein] CTD PMID:747652 aluminium phosphide increases activity ISO RGD:620687 6480464 aluminum phosphide results in increased activity of PYGL protein CTD PMID:20929055 alvocidib affects binding ISO RGD:731803 6480464 PYGL protein binds to alvocidib CTD PMID:11368340 amiodarone affects expression ISO RGD:620687 6480464 Amiodarone affects the expression of PYGL mRNA CTD PMID:19483382 ammonium chloride affects expression ISO RGD:620687 6480464 Ammonium Chloride affects the expression of PYGL mRNA CTD PMID:16483693 arsenite(3-) multiple interactions EXP 6480464 arsenite inhibits the reaction [INS protein results in decreased activity of PYGL protein] CTD PMID:28952001 arsenous acid increases expression ISO RGD:731803 6480464 Arsenic Trioxide results in increased expression of PYGL mRNA CTD PMID:20458559 atrazine increases expression ISO RGD:731803 6480464 Atrazine results in increased expression of PYGL mRNA CTD PMID:22378314 benzamide decreases activity ISO RGD:731803 6480464 benzamide analog results in decreased activity of PYGL protein CTD PMID:19758809 benzbromarone affects expression ISO RGD:620687 6480464 Benzbromarone affects the expression of PYGL mRNA CTD PMID:19483382 benzo[a]pyrene decreases expression ISO RGD:620687 6480464 Benzo(a)pyrene results in decreased expression of PYGL mRNA CTD PMID:21839799 benzo[a]pyrene affects methylation ISO RGD:731803 6480464 Benzo(a)pyrene affects the methylation of PYGL promoter CTD PMID:27901495 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of PYGL mRNA CTD PMID:22228805 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:620687 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of PYGL promoter CTD PMID:23359474 bis(2-ethylhexyl) phthalate increases expression ISO RGD:731803 6480464 Diethylhexyl Phthalate results in increased expression of PYGL mRNA CTD PMID:31163220 bisphenol A multiple interactions ISO RGD:620687 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of PYGL promoter, [bisphenol A co-treated with Estradiol] results in increased expression of PYGL mRNA CTD PMID:23359474 , PMID:26496021 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PYGL protein CTD PMID:35999755 bisphenol A decreases expression ISO RGD:731803 6480464 bisphenol A results in decreased expression of PYGL protein CTD PMID:34186270 bisphenol A decreases expression ISO RGD:620687 6480464 bisphenol A results in decreased expression of PYGL mRNA CTD PMID:30816183 , PMID:32528016 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PYGL mRNA CTD PMID:30951980 bisphenol A increases expression ISO RGD:620687 6480464 bisphenol A results in increased expression of PYGL mRNA CTD PMID:25181051 Bisphenol B increases expression ISO RGD:731803 6480464 bisphenol B results in increased expression of PYGL protein CTD PMID:34186270 bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of PYGL mRNA CTD PMID:30951980 bisphenol F increases expression ISO RGD:731803 6480464 bisphenol F results in increased expression of PYGL protein CTD PMID:34186270 buspirone decreases expression ISO RGD:620687 6480464 Buspirone results in decreased expression of PYGL mRNA CTD PMID:24136188 cadmium dichloride increases expression ISO RGD:731803 6480464 Cadmium Chloride results in increased expression of PYGL mRNA CTD PMID:26472689 Calcimycin increases activity ISO RGD:620687 6480464 Calcimycin results in increased activity of PYGL protein CTD PMID:6430282 Calcimycin multiple interactions ISO RGD:620687 6480464 Calcium deficiency inhibits the reaction [Calcimycin results in increased activity of PYGL protein] CTD PMID:6430282 calcium atom multiple interactions ISO RGD:620687 6480464 [Phenylephrine co-treated with Calcium] results in increased activity of PYGL protein more ... CTD PMID:6430282 , PMID:747652 calcium(0) multiple interactions ISO RGD:620687 6480464 [Phenylephrine co-treated with Calcium] results in increased activity of PYGL protein more ... CTD PMID:6430282 , PMID:747652 carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25620056 chlordecone increases expression EXP 6480464 Chlordecone results in increased expression of PYGL mRNA CTD PMID:33711761 chloroacetaldehyde affects expression ISO RGD:731803 6480464 chloroacetaldehyde affects the expression of PYGL mRNA CTD PMID:25596134 chloroacetic acid decreases expression EXP 6480464 chloroacetic acid results in decreased expression of PYGL mRNA, chloroacetic acid results in decreased expression of PYGL protein CTD PMID:28189721 chloroform decreases expression ISO RGD:620687 6480464 Chloroform results in decreased expression of PYGL mRNA CTD PMID:17522070 chloropicrin increases expression ISO RGD:731803 6480464 chloropicrin results in increased expression of PYGL mRNA CTD PMID:26352163 chloropicrin decreases expression ISO RGD:731803 6480464 chloropicrin results in decreased expression of PYGL mRNA CTD PMID:28476498 ciguatoxin CTX1B affects expression EXP 6480464 Ciguatoxins affects the expression of PYGL mRNA CTD PMID:18353800 cisplatin decreases expression ISO RGD:731803 6480464 Cisplatin results in decreased expression of PYGL mRNA CTD PMID:25596134 cisplatin increases expression ISO RGD:731803 6480464 Cisplatin results in increased expression of PYGL mRNA CTD PMID:27392435 more ... clofibrate affects expression ISO RGD:620687 6480464 Clofibrate affects the expression of PYGL mRNA CTD PMID:19483382 clofibrate decreases expression ISO RGD:620687 6480464 Clofibrate results in decreased expression of PYGL protein CTD PMID:16470657 cobalt dichloride increases expression ISO RGD:620687 6480464 cobaltous chloride results in increased expression of PYGL mRNA CTD PMID:24386269 copper(II) sulfate decreases expression ISO RGD:731803 6480464 Copper Sulfate results in decreased expression of PYGL mRNA CTD PMID:19549813 Cuprizon increases expression ISO RGD:620687 6480464 Cuprizone results in increased expression of PYGL mRNA CTD PMID:26577399 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of PYGL mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO RGD:620687 6480464 Cyclosporine results in decreased expression of PYGL mRNA CTD PMID:25596134 cyclosporin A decreases expression ISO RGD:731803 6480464 Cyclosporine results in decreased expression of PYGL mRNA CTD PMID:25562108 , PMID:25596134 D-glucose multiple interactions ISO RGD:620687 6480464 Glucose inhibits the reaction [[Phenylephrine co-treated with Calcium] results in increased activity of PYGL protein] CTD PMID:747652 dexamethasone increases expression ISO RGD:731803 6480464 Dexamethasone results in increased expression of PYGL mRNA CTD PMID:25047013 dextran sulfate decreases expression EXP 6480464 Dextran Sulfate results in decreased expression of PYGL protein CTD PMID:35999755 diarsenic trioxide increases expression ISO RGD:731803 6480464 Arsenic Trioxide results in increased expression of PYGL mRNA CTD PMID:20458559 dibutyl phthalate multiple interactions ISO RGD:620687 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of PYGL promoter CTD PMID:23359474 dichlorvos increases activity ISO RGD:620687 6480464 Dichlorvos results in increased activity of PYGL protein CTD PMID:222008 Diosbulbin B increases expression EXP 6480464 diosbulbin B results in increased expression of PYGL mRNA CTD PMID:32148032 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of PYGL mRNA CTD PMID:20880076 dioxygen multiple interactions ISO RGD:620687 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of PYGL mRNA CTD PMID:33729688 dioxygen increases expression ISO RGD:731803 6480464 Oxygen deficiency results in increased expression of PYGL mRNA CTD PMID:25596134 dorsomorphin multiple interactions ISO RGD:731803 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:731803 6480464 Doxorubicin results in increased expression of PYGL mRNA CTD PMID:30031762 endosulfan decreases expression ISO RGD:620687 6480464 Endosulfan results in decreased expression of PYGL mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:731803 6480464 entinostat results in increased expression of PYGL mRNA CTD PMID:27188386 erythromycin estolate decreases expression ISO RGD:620687 6480464 Erythromycin Estolate results in decreased expression of PYGL mRNA CTD PMID:17522070 fenofibrate increases expression ISO RGD:620687 6480464 Fenofibrate results in increased expression of PYGL mRNA CTD PMID:25596134 Geniposide increases expression EXP 21079733 Geniposide increased expression of PYGL in serum RGD glafenine decreases expression ISO RGD:620687 6480464 Glafenine results in decreased expression of PYGL mRNA CTD PMID:24136188 glucose multiple interactions ISO RGD:620687 6480464 Glucose inhibits the reaction [[Phenylephrine co-treated with Calcium] results in increased activity of PYGL protein] CTD PMID:747652 glyphosate increases expression EXP 6480464 glyphosate results in increased expression of PYGL protein CTD PMID:37208198 glyphosate decreases expression EXP 6480464 glyphosate results in decreased expression of PYGL protein CTD PMID:36173347 ibuprofen increases expression ISO RGD:620687 6480464 Ibuprofen results in increased expression of PYGL mRNA CTD PMID:25596134 ifosfamide decreases expression ISO RGD:731803 6480464 Ifosfamide results in decreased expression of PYGL mRNA CTD PMID:25596134 isoprenaline increases activity ISO RGD:620687 6480464 Isoproterenol results in increased activity of PYGL protein CTD PMID:6430282 ivermectin decreases expression ISO RGD:731803 6480464 Ivermectin results in decreased expression of PYGL protein CTD PMID:32959892 ketoconazole increases expression ISO RGD:620687 6480464 Ketoconazole results in increased expression of PYGL mRNA CTD PMID:37077353 L-ethionine affects expression ISO RGD:620687 6480464 Ethionine affects the expression of PYGL mRNA CTD PMID:19483382 malathion multiple interactions ISO RGD:620687 6480464 Acetylcysteine inhibits the reaction [Malathion results in increased expression of PYGL mRNA] CTD PMID:25449180 malathion increases expression ISO RGD:620687 6480464 Malathion results in increased expression of PYGL mRNA CTD PMID:25449180 metformin decreases expression ISO RGD:620687 6480464 Metformin results in decreased expression of PYGL mRNA CTD PMID:25596134 methylarsonite multiple interactions EXP 6480464 methylarsonite inhibits the reaction [INS protein results in decreased activity of PYGL protein] CTD PMID:28952001 methylmercury chloride decreases expression ISO RGD:731803 6480464 methylmercuric chloride results in decreased expression of PYGL mRNA CTD PMID:23179753 , PMID:27188386 Muraglitazar increases expression ISO RGD:620687 6480464 muraglitazar results in increased expression of PYGL mRNA CTD PMID:21515302 N-acetyl-L-cysteine multiple interactions ISO RGD:620687 6480464 Acetylcysteine inhibits the reaction [Malathion results in increased expression of PYGL mRNA] CTD PMID:25449180 N-nitrosomorpholine decreases expression ISO RGD:620687 6480464 N-nitrosomorpholine results in decreased expression of PYGL protein CTD PMID:2885971 N-nitrosomorpholine affects expression ISO RGD:620687 6480464 N-nitrosomorpholine affects the expression of PYGL protein CTD PMID:19716841 nefazodone decreases expression ISO RGD:620687 6480464 nefazodone results in decreased expression of PYGL mRNA CTD PMID:24136188 neostigmine increases activity ISO RGD:620687 6480464 Neostigmine results in increased activity of PYGL protein modified form CTD PMID:1350317 neostigmine multiple interactions ISO RGD:620687 6480464 Phentolamine inhibits the reaction [Neostigmine results in increased activity of PYGL protein modified form] CTD PMID:1350317 nickel dichloride affects expression ISO RGD:620687 6480464 nickel chloride affects the expression of PYGL mRNA CTD PMID:22110744 nicotinamide multiple interactions ISO RGD:620687 6480464 [Streptozocin co-treated with Niacinamide] affects the activity of PYGL protein, resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] affects the activity of PYGL protein] CTD PMID:19059388 nimesulide decreases expression ISO RGD:620687 6480464 nimesulide results in decreased expression of PYGL mRNA CTD PMID:24136188 nitrofen increases expression ISO RGD:620687 6480464 nitrofen results in increased expression of PYGL mRNA CTD PMID:33484710 omeprazole affects expression ISO RGD:620687 6480464 Omeprazole affects the expression of PYGL mRNA CTD PMID:19483382 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PYGL mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of PYGL mRNA CTD PMID:34911549 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of PYGL mRNA CTD PMID:17562736 paracetamol multiple interactions EXP 6480464 PANX1 gene mutant form inhibits the reaction [Acetaminophen results in decreased expression of PYGL mRNA] CTD PMID:29246445 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of PYGL mRNA CTD PMID:29246445 paracetamol multiple interactions ISO RGD:731803 6480464 [Dietary Carbohydrates co-treated with Acetaminophen] results in increased expression of PYGL mRNA CTD PMID:17093179 paracetamol decreases expression ISO RGD:620687 6480464 Acetaminophen results in decreased expression of PYGL mRNA CTD PMID:17522070 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:620687 6480464 perfluorooctane sulfonic acid results in decreased expression of PYGL mRNA CTD PMID:19162173 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PYGL mRNA CTD PMID:36331819 perfluorooctanoic acid decreases expression ISO RGD:620687 6480464 perfluorooctanoic acid results in decreased expression of PYGL mRNA, perfluorooctanoic acid results in decreased expression of PYGL protein CTD PMID:19162173 , PMID:34958885 phentolamine multiple interactions ISO RGD:620687 6480464 Phentolamine inhibits the reaction [Neostigmine results in increased activity of PYGL protein modified form] CTD PMID:1350317 phenylephrine multiple interactions ISO RGD:620687 6480464 [Phenylephrine co-treated with Calcium] results in increased activity of PYGL protein, Glucose inhibits the reaction [[Phenylephrine co-treated with Calcium] results in increased activity of PYGL protein] CTD PMID:747652 phenylephrine increases expression ISO RGD:620687 6480464 Phenylephrine results in increased expression of PYGL mRNA CTD PMID:18158353 pirinixic acid affects expression ISO RGD:620687 6480464 pirinixic acid affects the expression of PYGL mRNA CTD PMID:19483382 potassium chromate increases expression ISO RGD:731803 6480464 potassium chromate(VI) results in increased expression of PYGL mRNA CTD PMID:22714537 procyanidin B1 decreases activity ISO RGD:731803 6480464 procyanidin B1 results in decreased activity of PYGL protein CTD PMID:34342938 procyanidin B1 decreases activity EXP 6480464 procyanidin B1 results in decreased activity of PYGL protein CTD PMID:34342938 procyanidin B1 multiple interactions ISO RGD:731803 6480464 [procyanidin B1 co-treated with p-coumaric acid] results in decreased activity of PYGL protein CTD PMID:34342938 procyanidin B1 multiple interactions EXP 6480464 [procyanidin B1 co-treated with p-coumaric acid] results in decreased activity of PYGL protein CTD PMID:34342938 pyrogallol increases expression EXP 6480464 Pyrogallol results in increased expression of PYGL mRNA CTD PMID:20362636 rac-lactic acid decreases expression ISO RGD:731803 6480464 Lactic Acid results in decreased expression of PYGL mRNA CTD PMID:30851411 resveratrol multiple interactions ISO RGD:620687 6480464 resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] affects the activity of PYGL protein] CTD PMID:19059388 rotenone decreases expression ISO RGD:620687 6480464 Rotenone results in decreased expression of PYGL mRNA CTD PMID:28374803 rotenone increases expression ISO RGD:731803 6480464 Rotenone results in increased expression of PYGL mRNA CTD PMID:29955902 SB 431542 multiple interactions ISO RGD:731803 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium dichromate decreases expression ISO RGD:620687 6480464 sodium bichromate results in decreased expression of PYGL mRNA CTD PMID:25993096 streptozocin multiple interactions ISO RGD:620687 6480464 [Streptozocin co-treated with Niacinamide] affects the activity of PYGL protein, resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] affects the activity of PYGL protein] CTD PMID:19059388 streptozocin decreases expression ISO RGD:620687 6480464 Streptozocin results in decreased expression of PYGL mRNA CTD PMID:25905778 sunitinib decreases expression ISO RGD:731803 6480464 Sunitinib results in decreased expression of PYGL mRNA CTD PMID:31533062 temozolomide increases expression ISO RGD:731803 6480464 Temozolomide results in increased expression of PYGL mRNA CTD PMID:31758290 tert-butyl hydroperoxide increases expression ISO RGD:731803 6480464 tert-Butylhydroperoxide results in increased expression of PYGL mRNA CTD PMID:15336504 Tesaglitazar increases expression ISO RGD:620687 6480464 tesaglitazar results in increased expression of PYGL mRNA CTD PMID:21515302 testosterone decreases expression ISO RGD:731803 6480464 Testosterone results in decreased expression of PYGL mRNA CTD PMID:33359661 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of PYGL mRNA CTD PMID:17484886 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of PYGL mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane decreases expression ISO RGD:620687 6480464 Carbon Tetrachloride results in decreased expression of PYGL mRNA CTD PMID:17522070 , PMID:31150632 tetrachloromethane affects expression ISO RGD:620687 6480464 Carbon Tetrachloride affects the expression of PYGL mRNA CTD PMID:15963342 tetracycline decreases expression ISO RGD:620687 6480464 Tetracycline results in decreased expression of PYGL mRNA CTD PMID:17522070 thimerosal decreases expression ISO RGD:731803 6480464 Thimerosal results in decreased expression of PYGL mRNA CTD PMID:27188386 thioacetamide affects expression ISO RGD:620687 6480464 Thioacetamide affects the expression of PYGL mRNA CTD PMID:19483382 thioacetamide decreases expression ISO RGD:620687 6480464 Thioacetamide results in decreased expression of PYGL mRNA CTD PMID:34492290 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of PYGL mRNA CTD PMID:23409001 titanium dioxide affects expression EXP 6480464 titanium dioxide affects the expression of PYGL mRNA CTD PMID:17656681 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of PYGL mRNA CTD PMID:23557971 trichostatin A increases expression ISO RGD:731803 6480464 trichostatin A results in increased expression of PYGL mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:731803 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PYGL mRNA CTD PMID:27188386 Triptolide decreases expression ISO RGD:620687 6480464 triptolide results in decreased expression of PYGL mRNA CTD PMID:23639586 troglitazone decreases expression ISO RGD:620687 6480464 troglitazone results in decreased expression of PYGL mRNA, troglitazone results in decreased expression of PYGL protein CTD PMID:21315101 , PMID:21515302 tungsten decreases expression EXP 6480464 Tungsten results in decreased expression of PYGL mRNA CTD PMID:30912803 valdecoxib decreases expression ISO RGD:620687 6480464 valdecoxib results in decreased expression of PYGL mRNA CTD PMID:24136188 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of PYGL mRNA CTD PMID:21427059 valproic acid affects expression ISO RGD:731803 6480464 Valproic Acid affects the expression of PYGL mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:731803 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PYGL mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:731803 6480464 Valproic Acid results in increased expression of PYGL mRNA CTD PMID:19101580 more ... vanillin affects binding ISO RGD:731803 6480464 vanillin binds to PYGL protein CTD PMID:33823243 vorinostat multiple interactions ISO RGD:731803 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PYGL mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:731803 6480464 vorinostat results in increased expression of PYGL mRNA CTD PMID:26272509 zoledronic acid decreases expression ISO RGD:731803 6480464 zoledronic acid results in decreased expression of PYGL mRNA CTD PMID:25596134